Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.3 HKD 0.3% Market Closed
Market Cap: 60.5B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note

Sino Biopharmaceutical Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sino Biopharmaceutical Ltd
Accounts Receivables Peer Comparison

Comparables:
G
512
U
3933
C
570
C
3320
H
13

Competitive Accounts Receivables Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Sino Biopharmaceutical Ltd
HKEX:1177
Accounts Receivables
ÂĄ7.2B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
16%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Accounts Receivables
HK$4.5B
CAGR 3-Years
41%
CAGR 5-Years
27%
CAGR 10-Years
21%
U
United Laboratories International Holdings Ltd
HKEX:3933
Accounts Receivables
ÂĄ5.4B
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
13%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Accounts Receivables
ÂĄ10.3B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
26%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Accounts Receivables
HK$77.7B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Accounts Receivables
$159.8m
CAGR 3-Years
39%
CAGR 5-Years
30%
CAGR 10-Years
20%

See Also

What is Sino Biopharmaceutical Ltd's Accounts Receivables?
Accounts Receivables
7.2B CNY

Based on the financial report for Jun 30, 2024, Sino Biopharmaceutical Ltd's Accounts Receivables amounts to 7.2B CNY.

What is Sino Biopharmaceutical Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
16%

Over the last year, the Accounts Receivables growth was 1%. The average annual Accounts Receivables growth rates for Sino Biopharmaceutical Ltd have been 13% over the past three years , 15% over the past five years , and 16% over the past ten years .

Back to Top